3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma

被引:20
|
作者
Hu, Cong-Li [1 ,2 ,3 ]
Zhang, Yan-Jun [4 ]
Zhang, Xiao-Feng [2 ,3 ]
Fei, Xiang [5 ]
Zhang, Hai [6 ]
Li, Chun-Guang [5 ]
Sun, Bin [2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Translat Med Ctr, Shanghai 201620, Peoples R China
[2] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Mol Oncol, Shanghai 200438, Peoples R China
[3] Second Mil Med Univ, Natl Ctr Liver Canc, Shanghai 200438, Peoples R China
[4] Shanghai Urban Construct Vocat Coll, Sch Hlth & Social Care, Shanghai 201415, Peoples R China
[5] Second Mil Med Univ, Changhai Hosp, Dept Thorac Surg, 225 Changhai Rd, Shanghai 200438, Peoples R China
[6] Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Pharm, Sch Med, Shanghai 201204, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2021年 / 14卷
基金
中国国家自然科学基金;
关键词
3D culture; circulating tumor cells; early recurrence; metastasis; hepatocellular carcinoma; BREAST-CANCER; INITIATING CELLS; SURVIVAL; EPCAM; PROGRESSION; CATENIN; MICROEMBOLI;
D O I
10.2147/OTT.S298427
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Purpose: Circulating tumor cells (CTCs) are considered to be a key factor involved in tumor metastasis. However, the isolation and culture of CTCs in vitro remains challenging, and their clinical application for predicting prognosis and survival is still limited. The development of accurate evaluating system for CTCs will benefit for clinical assessment of HCC. Methods: Density gradient centrifugation and magnetic separation based on CD45 antibody were used to isolate CTCs. 3D culture was used to maintain and amplify CTCs and HCC cells. Cellular immunofluorescence was used to identify CTCs and spheroids. The cutoff value of CTC spheroid was calculated using X-tile software. The relationship between clinicopathological variables and CTC spheroids in HCC patients is analyzed. In vivo models were used to evaluate tumor growth and metastasis of CTC spheroids. Results: Patient-derived CTCs/HCC cells were isolated and expanded to form spheroids using 3D culture. CTC spheroids could be used to predict short-term recurrence of CTCs compared with conventional CTC enumeration. Different cell lines exhibited different formation rates and grew to different sizes. Identification of CTC spheroids revealed that EpCAM and beta-catenin were expressed in spheroids derived from HCC cells and in the HCC/CTCs. EpCAM-positive HCC cells exhibited improved spheroid formation in 3D culture and were more tumorigenic and likely to metastasize to the lung in vivo. Abnormal activation of the Wnt/beta-catenin signaling pathway was observed in EpCAM positive cells. Conclusion: CTC spheroids could predict prognosis of HCC more precisely compared with conventional CTC enumeration. EpCAM may participate in the formation and survival of CTC spheroids which dependent on Wnt/beta-catenin signaling pathway.
引用
收藏
页码:2673 / 2688
页数:16
相关论文
共 50 条
  • [1] Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis
    Yu Zhang
    Zhi-Long Shi
    Xia Yang
    Zheng-Feng Yin
    World Journal of Gastroenterology, 2014, (01) : 142 - 147
  • [2] Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis
    Zhang, Yu
    Shi, Zhi-Long
    Yang, Xia
    Yin, Zheng-Feng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (01) : 142 - 147
  • [3] Usage of circulating tumor cells for tumor recurrence prognosis in liver transplantation patients with hepatocellular carcinoma
    Chen, M.
    Lin, X.
    Chen, Z.
    Ju, W.
    He, X.
    TRANSPLANTATION, 2021, 105 (08) : 38 - 39
  • [4] Association of phenotypic transformation of circulating tumor cells and early recurrence in patients with hepatocellular carcinoma following liver transplantation
    Xie, Yun-Liang
    Yang, Zhou
    Feng, Xiao
    Yang, Qing
    Ye, Lin-Sen
    Li, Xiao-Bin
    Tang, Hui
    Zhang, Ying-Cai
    Liu, Wei
    Zhang, Tong
    Fu, Bin-Sheng
    Yi, Shu-Hong
    Yang, Yang
    Chen, Gui-Hua
    ASIAN JOURNAL OF SURGERY, 2022, 45 (01) : 435 - 440
  • [5] ASSOCIATION OF DETECTION AND CLASSIFICATION OF CIRCULATING TUMOR CELLS AND EARLY RECURRENCE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA FOLLOWING LIVER TRANSPLANTATION
    Fu, Binsheng
    Yang, Qing
    Yi, Shuhong
    Zhang, Yi
    Xie, Yunliang
    Yang, Yang
    Chen, Guihua
    HEPATOLOGY, 2019, 70 : 89A - 90A
  • [6] Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation
    Wang, Shaoping
    Zheng, Yujian
    Liu, Jun
    Huo, Feng
    Zhou, Jie
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (05) : 929 - 934
  • [7] Prognostic Index of Circulating Tumor Cells for Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation
    Chen, M.
    Chen, Z.
    Lin, X.
    Ju, W.
    He, X.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 493 - 493
  • [8] Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
    Zhu, Gui-Qi
    Liu, Wei-Ren
    Tang, Zheng
    Qu, Wei-Feng
    Fang, Yuan
    Jiang, Xi-Fei
    Song, Shu-Shu
    Wang, Han
    Tao, Chen-Yang
    Zhou, Pei-Yun
    Huang, Run
    Gao, Jun
    Sun, Hai-Xiang
    Ding, Zhen-Bin
    Peng, Yuan-Fei
    Dai, Zhi
    Zhou, Jian
    Fan, Jia
    Shi, Ying-Hong
    MOLECULAR ONCOLOGY, 2022, 16 (02) : 549 - 561
  • [9] Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
    Lu, Zhan
    Ni, Hanghang
    Yang, Xihua
    Tan, Lihao
    Zhuang, Haixiao
    Mo, Yunning
    Wei, Xingyu
    Qi, Lunan
    Xiang, Bangde
    BMC CANCER, 2023, 23 (01)
  • [10] Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
    Zhan Lu
    Hanghang Ni
    Xihua Yang
    Lihao Tan
    Haixiao Zhuang
    Yunning Mo
    Xingyu Wei
    Lunan Qi
    Bangde Xiang
    BMC Cancer, 23